Quantitative monitoring of serum hepatitis B virus DNA and blood lymphocyte subsets during combined prednisolone and interferon-α therapy in patients with chronic hepatitis B

Journal of Viral Hepatitis

Volumn 6, Issue 3, 1999, Pages 219-227

  Fei, G Z ^a,b   Sylvan, S P E ^a,b   Yao, G B ^a   Hellstrom U B ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Jingan Qu Central Hospital   (China)

Author keywords

Chronic active hepatitis; HBV DNA; Hepatitis B virus; Interferon prednisolone; T cell subsets

Indexed keywords

PREDNISOLONE; RECOMBINANT ALPHA2B INTERFERON;

ADULT; ARTICLE; CAUCASIAN; CHINA; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; HEPATITIS B; HUMAN; IMMUNOMODULATION; IMMUNOTHERAPY; LEUKOCYTE COUNT; LIVER FUNCTION TEST; LYMPHOCYTE SUBPOPULATION; MONONUCLEAR CELL; ORAL DRUG ADMINISTRATION; PATIENT MONITORING; PRIORITY JOURNAL; QUANTITATIVE ASSAY; T LYMPHOCYTE SUBPOPULATION; TREATMENT OUTCOME; VIRUS LOAD; VIRUS REPLICATION;

ADULT; ANTIVIRAL AGENTS; CD4-CD8 RATIO; DNA, VIRAL; DRUG THERAPY, COMBINATION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GLUCOCORTICOIDS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; PREDNISOLONE; T-LYMPHOCYTE SUBSETS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 0032977216     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.1999.00157.x     Document Type: Article

References (43)

1. Chisari FV, Ferrari C. Viral hepatitis. In: Nathanson N, Ahmed R, Gonzalez-Scarano F et al., eds. Viral Pathogenesis. Philadelphia: Lippincott-Raven Publishers, 1997: 745-778.
2. Reinherz EL, Kung PC, Goldstein G, Schlossman SF. Separation of functional subsets of human T cells by a monoclonal antibody. Proc Natl Acad Sci USA 1979; 76: 4061-4065.
3. Reinherz EL, Kung PC, Goldstein G, Schlossman SF. A monoclonal antibody reactive with the human cytotoxic/suppressorT cell subset previously defined by a heteroantiserum termed TH2. J Immunol 1980; 124: 1301-1308.
4. Ferrari C, Mondelli MU, Penna A, Fiaccadori F, Chisari FV. Functional characterization of cloned intrahepatic, hepatitis B virus nucleoprotein-specific helper T cell lines. J Immunol 1987; 139: 539-544.
5. Barnaba V, Franco A, Paroli M et al. Selective expansion of cytotoxic T lymphocytes with a CD4+CD56+ surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with hepatitis B virus. J Immunol 1994; 152: 3074-3087.
6. Thomas HC. T cell subsets in patients with acute and chronic HBV infection, primary biliary cirrhosis and alcohol induced liver disease. Int J Immunopharmacol 1981; 3: 301-305.
7. Thomas HC, Brown D, Routhier G et al. Inducer and suppressor T-cells in hepatitis B virus-induced liver disease. Hepatology 1982; 2: 202-204.
8. Carella G, Chatenoud L, Degos F, Bach M-A. Regulatory T cell-subset imbalance in chronic active hepatitis. J Clin Immunol 1982; 2: 93-100.
9. Alexander GJM, Nouri-Aria K-T, Eddleston ALWF, Williams R. Contrasting relations between suppressor-cell function and suppressor-cell number in chronic liver disease. Lancet 1983; 1: 1291-1293.
10. Barnaba V, Zaccari C, Levrero M, Ruocco G, Balsano F. Immunoregulatory T cells in HBV-induced chronic liver disease as defined by monoclonal antibodies. Clin Immunol Immunopathol 1983; 26: 83-90.
11. Barnaba V, Musca A, Cordova C et al. Relationship between T cell subsets and suppressor cell activity in chronic hepatitis B virus (HBV) infection. Clin Exp Immunol 1983; 53: 281-288.
12. Pignata C, Vajro P, Troncone R, Monaco G, Ciriaco M. Immunoregulatory T subsets in chronic active viral hepatitis: Characterization by monoclonal antibodies. J Pediatr Gastroenterol Nutr 1983; 2: 229-233.
13. Dworniak D, Tchórzewski H, Pokoca L, Tkacz B, Drobnik S, Baj Z. T lymphocyte subpopulations in patients with chronic active hepatitis B virus infection characterized by monoclonal antibodies. Arch Immunol Ther Exp 1989; 37: 305-311.
14. Chu C-M, Liaw Y-F, Yang C-Y, Sheen I-S. Peripheral T-cell subsets in chronic type B hepatitis: correlation with biochemical and histological activities and hepatitis B e antigen/antibody status. Cell Immunol 1984; 86: 562-566.
15. Liu F, Song P-H, Hao L-J. The relationship between T cell subsets and suppressor cell function in hepatitis B. J Tongi Med Univ 1987; 7: 111-116.
16. Jang TW, Koo JY, Park BC. Relationship between T-lymphocyte subsets and suppressor cell activity in patients with chronic active hepatitis B. Korean J Intern Med 1989; 4: 41-47.
17. Dooley JS, Davis GL, Peters M, Waggoner JG, Goodman J, Hoofnagle JH. Pilot study of recombinant human α-interferon for chronic type B hepatitis. Gastroenterology 1986; 90: 150-157.
18. Scully LJ, Brown D, Lloyd C, Shein R, Thomas HC. Immunological studies before and during interferon therapy in chronic HBV infection: identification of factors predicting response. Hepatology 1990; 12: 1111-1117.
19. Tsuji H, Murai K, Akagi K, Fujishima M. Effects of recombinant leukocyte interferon on serum immunoglobulin concentrations and lymphocyte subpopulations in chronic hepatitis B. J Clin Immunol 1990; 10: 38-44.
20. Hayata T, Nakano Y, Yoshizawa K, Sodeyama T, Kiyosawa K. Effects of interferon on intrahepatic human leukocyte antigens and lymphocyte subsets in patients with chronic hepatitis B and C. Hepatology 1991; 13: 1022-1028.
21. Sing G, Butterworth L, Chen X, Bryant A, Cooksley G. Composition of peripheral blood lymphocyte populations during different stages of chronic infection with hepatitis B virus. J Viral Hep 1998; 5: 83-93.
22. Klein A, Pappas SC, Gordon P et al. The effect of nonviral liver damage on the T-lymphocyte helper/suppressor ratio. Clin Immunol Immunopathol 1988; 46: 214-220.
23. Pawlotsky J-M, Bastie A, Lonjon I et al. What technique should be used for routine detection and quantification of HBV DNA in clinical samples? J Virol Methods 1997; 65: 245-253.
24. Gocke DJ, Ackley AM, Kim HC, Benson GD. Alterations in helper and suppressor T lymphocytes in hepatitis. Hepatology 1981; 1: 511 (abstr).
25. Klingenstein RJ, Savarese AM, Dienstag JL, Rubin RH, Bhan AK. Immunoregulatory T cell subsets in acute and chronic hepatitis. Hepatology 1981; 1: 523 (abstr).
26. Regenstein FG, Roodman ST, Perrillo RP. Immunoregulatory T cell subsets in chronic hepatitis B virus infection: the influence of homosexuality. Hepatology 1983; 3: 951-954.
27. Si L, Whiteside TL, Schade RR, Van Thiel DH. Studies of lymphocyte subpopulations in the liver tissue and blood of patients with chronic active hepatitis (CAH). J Clin Immunol 1983; 3: 408-419.
28. Van Hattum J, Van Oudenaren A, Schalm SW, Visser JWM, Benner R. T-lymphocyte subpopulations in patients with various courses after hepatitis B virus infection. Scand J Gastroenterol 1984; 19: 497-501.
29. Hasegawa K, Yamauchi K, Furukawa T, Obata H. Dual color fluorescence analysis of peripheral T cell subsets in hepatitis B virus-induced liver disease. Hepatology 1988; 8: 1134-1137.
30. Onji M, Kondo H, Ohta Y. Serial observation of lymphocyte subpopulations and interleukin 2 production of T cells from patients with acute viral hepatitis and chronic active hepatitis. Hepatol Gastroenterol 1988; 35: 10-13.
31. Newman JT, Nicodemus DS, Ordonez GA, Stone MJ. Lymphocyte phenotyping by fluorescence microscope and flow cytometry: results in homosexual men and heterosexual controls. AIDS Research 1984; 1: 127-134.
32. Perrillo RP, Schiff ER, Davis GL et al. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. N Engl J Med 1990; 323: 295-301.
33. Fevery J, Elewaut A, Michielsen P et al. Efficacy of interferon alfa-2b with or without prednisone withdrawal in the treatment of chronic viral hepatitis B. A prospective double-blind Belgian-Dutch study. J Hepatol 1990; 11: S108-S112.
34. Cupps TR, Fauci AS. Corticosteroid-mediated immunoregulation in man. Immunol Rev 1982; 65: 133-155.
35. Hanson RG, Peters MG, Hoofnagle JH. Effects of immunosuppressive therapy with prednisolone on B and T lymphocyte function in patients with chronic type B hepatitis. Hepatology 1986; 6: 173-179.
36. Bernard F, Raymond G, Willems B, Villeneuve J-P. Quantitative assessment of serum hepatitis B e antigen, IgM hepatitis B core antibody and HBV DNA in monitoring the response to treatment in patients with chronic hepatitis B. J Viral Hep 1997; 4: 265-272.
37. Chisari FV. Hepatitis B virus transgenic mice: insights into the virus and the disease. Hepatology 1995; 22: 1316-1325.
38. Taylor JL, Grossberg SE. The effects of interferon-α on the production and action of other cytokines. Semin Oncol 1998; 25 (suppll): 23-29.
39. Schandené L, Cogan E, Crusiaux A, Coldman M. Interferon-α upregulates both interleukin-10 and interferon-γ production by human CD4+ T cells. Blood 1997; 89: 1110-1111.
40. Sjogren MH, Hoofnagle JH, Waggoner JG. Effect of corticosteroid therapy on levels of antibody to hepatitis B core antigen in patients with chronic type B hepatitis. Hepatology 1987; 7: 582-585.
41. Peters M, Walling DM, Kelly K, Davis GL, Waggoner JG, Hoofnagle JH. Immunologic effects of interferon-α in man: treatment with human recombinant interferon-α suppresses in vitro immunoglobulin production in patients with chronic type B hepatitis. J Immunol 1986; 137: 3147-3152.
42. Fei GZ, Sylvan SPE, Hellström UB, Yao GB. IgM antipreS2 monitoring during combined corticosteroid/interferon-alpha 2b therapy in chronic hepatitis B. Liver 1991; 11: 358-364.
43. Marinos G, Smith HM, Naoumov NV, Williams R. Quantitative assessment of serum IgM anti-HBc in the natural course and during interferon treatment of chronic hepatitis B virus infection. Hepatology 1994; 19: 303-311.